Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Acadia Healthcare Company (ACHC) Common Equity (2016 - 2025)

Historic Common Equity for Acadia Healthcare Company (ACHC) over the last 16 years, with Q3 2025 value amounting to $3.1 billion.

  • Acadia Healthcare Company's Common Equity rose 292.85% to $3.1 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $3.1 billion, marking a year-over-year increase of 292.85%. This contributed to the annual value of $3.1 billion for FY2024, which is 1048.68% up from last year.
  • Per Acadia Healthcare Company's latest filing, its Common Equity stood at $3.1 billion for Q3 2025, which was up 292.85% from $3.1 billion recorded in Q2 2025.
  • Over the past 5 years, Acadia Healthcare Company's Common Equity peaked at $3.1 billion during Q3 2025, and registered a low of $2.3 billion during Q1 2021.
  • Over the past 5 years, Acadia Healthcare Company's median Common Equity value was $2.8 billion (recorded in 2022), while the average stood at $2.8 billion.
  • Data for Acadia Healthcare Company's Common Equity shows a peak YoY increase of 3253.74% (in 2021) and a maximum YoY decrease of 674.34% (in 2021) over the last 5 years.
  • Acadia Healthcare Company's Common Equity (Quarter) stood at $2.5 billion in 2021, then rose by 11.73% to $2.8 billion in 2022, then fell by 1.09% to $2.8 billion in 2023, then rose by 10.49% to $3.1 billion in 2024, then increased by 1.52% to $3.1 billion in 2025.
  • Its last three reported values are $3.1 billion in Q3 2025, $3.1 billion for Q2 2025, and $3.0 billion during Q1 2025.